Literature DB >> 7491825

[AIDS prevention in European prisons].

G Schaller1, T W Harding.   

Abstract

Informations on HIV/AIDS in prisons which include 32 prison-systems in 17 European countries have been collected. The principle of equivalence of preventive measures and health care between prisons and the outside community, prison authorities should strive to prevent HIV transmission in prisons. There have been major developments in effective prevention programmes in the community, there has been less progress within the prison-systems. Information on AIDS is provided to prisoners in almost all prison-systems. While condom distribution is practiced in a growing number of systems, no prison systems have adopted syringes/needle distribution or exchange during incarceration. A few system have accepted distribution of a disinfectant (diluted bleach) with instruction on cleaning injection materials. Despite clear recommendations made by international bodies in 1987/88, it must be concluded that discrimination and segregation (restriction from access to workshops, specially work in kitchens) remain widespread in 1992.

Entities:  

Mesh:

Year:  1995        PMID: 7491825     DOI: 10.1007/bf01299197

Source DB:  PubMed          Journal:  Soz Praventivmed        ISSN: 0303-8408


  4 in total

1.  Seropositivity for HTLV-1 among Italian prisoners.

Authors:  G Marinucci; C Di Giacomo; A Dato; F Ceralli; M Taborchi; C Galli; M Canavaggio; H Lee
Journal:  AIDS       Date:  1990-09       Impact factor: 4.177

2.  Seroepidemiology of HIV-1 infection in a Catalonian penitentiary.

Authors:  V Martin; J M Bayas; A Laliga; T Pumarola; J Vidal; M T Jiménez de Anta; L Salleras
Journal:  AIDS       Date:  1990-10       Impact factor: 4.177

3.  Seroepidemiological survey of transmissible infections in Portuguese prisoners.

Authors:  A Meliço-Silvestre; V Pombo; A Pereira; R Lopes; R Corte-Real
Journal:  AIDS       Date:  1991-06       Impact factor: 4.177

4.  AIDS in prison.

Authors:  T W Harding
Journal:  Lancet       Date:  1987-11-28       Impact factor: 79.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.